Reunion Neuroscience (REUN) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 58 252 sessions, August 4, 2022 to August 4, 2023
- Largest daily move
- +58% close of June 1, 2023
- 1-year change
- -73% closing prices, August 4, 2022 to August 4, 2023
- 1-month change
- +0.9% closing prices, July 3, 2023 to August 4, 2023
Company Description
Reunion Neuroscience (NASDAQ: REUN) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $13.0M.
REUN has declined 73.0% over the past year. The last closing price was $1.12.
This page collects what Stock Titan holds for REUN, including price data and latest news.
Stock Performance
Reunion Neuroscience (REUN) closed at $1.12 on August 4, 2023. Over the past 12 months, the price has lost 73.0%.
REUN Metrics & Rankings
Price returns through August 4, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Reunion Neuroscience has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include conferences, clinical trial, fda approval, earnings. View all REUN news →
SEC Filings
REUN Company Profile & Sector Positioning
Reunion Neuroscience (REUN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing REUN often look at related companies in the same sector, including BiomX Inc. (PHGE), Phio Pharmaceuticals Corp. (PHIO), Abpro Holdings, Inc (ABP), Imunon, Inc. (IMNN), and Celyad Oncology (CYAD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REUN's relative position within its industry.